December 3, 2024 - Provider Annual Orientation and Training Webinar Announcement Reminder Jefferson Health Plans is hosting our 4th quarter Provider Orientation and Training Webinar on Wednesday, December 11, 2024
And one in five have taken the medication in the past
A 2,700person realworld study presented at the 2025 European Congress on Obesity showed an average 16% weightloss over 64 weeks at microdose levels of semaglutide
Research Evidence Comparison# Retatrutide Research# The pivotal Phase 2 trial (Jastreboff et al., NEJM 2023) enrolled 338 adults with obesity and demonstrated weight reductions of up to 24.2% at 48 weeks
For folks with T1D, off-label use is promising but complex, and requires close watchfulness
Fat Reduction 1064 nm Diode Laser Laser fat reduction treatments use advanced diode laser technology to target and heat fat cells beneath the skin